← Back

Biodefense Compound Screening

13.2M/sec

Compounds screened per second against any pathogen target. H5N1. Anthrax. Plague. Smallpox. Ebola.
Computational countermeasure candidate portfolios — experimental validation required before deployment.

The Gap

Pandemics move in days.
Drug discovery took years.

COVID-19 killed millions before effective treatments reached patients. The bottleneck was not biology — the virus was sequenced within days. The bottleneck was the time to screen, filter, and validate compounds against the target. 22Rx runs that screen at 13.2 million compounds per second. A computationally ranked candidate portfolio in hours — synthesis and validation still required.

13.2M
Compound screens per second
6 min
COVID target retrospective demo surfaced Paxlovid-class and Remdesivir-class scaffolds in ~6 min (speed benchmark)
60%
H5N1 case fatality rate — no approved treatment
BARDA Priority Threats

Every tier-1 biodefense threat.
Computational candidate portfolios.

Pathogen Current Status 22Rx Approach Mechanism
H5N1 Avian Influenza No approved treatment. Oseltamivir partial. HA-fusion inhibitor candidates (computational) Novel — no resistance possible
Anthrax (B. anthracis) Ciprofloxacin + antitoxin LF protease inhibitor candidates (computational) Toxin neutralization
Plague (Y. pestis) Streptomycin (resistance risk) Type III secretion blocker candidates (computational) Virulence disruption
Smallpox (Variola) Tecovirimat only Viral polymerase inhibitor candidates (computational) Replication block
Ebola / Marburg mAbs — IV only, limited supply VP40 matrix protein blocker candidates (computational) Budding inhibition
Novel pathogen (day zero) Years Hours Sequence → screen → candidate
Field Deployment

Not just discovery.
Deployable anywhere.

01
Sequence-to-Screen
Pathogen sequence received → target protein modeled → compound library screened. No human intervention required between sequence receipt and hit list delivery.
02
Multi-Pathogen Parallel
Screen against multiple threat organisms simultaneously. One lock-free compute cluster handles concurrent screens without performance degradation.
03
Resistance Prediction
LoNC models mutation escape pathways before treatment begins. Pre-designed second and third-line compounds ready before resistance emerges.
04
Field Hardware
Runs on commodity CPU hardware. No GPU, no specialized equipment. Forward operating base with a standard server can run the full screening pipeline.
Coverage

Every threat class.
Bacteria. Virus. Toxin.

H5N1 / H7N9 pandemic influenza
SARS-CoV-3 (future) pandemic preparedness
Anthrax BARDA Cat A
Plague BARDA Cat A
Smallpox BARDA Cat A
Ebola / Marburg BARDA Cat A
Botulinum toxin weaponizable
VX / Novichok antidotes nerve agents
Drug-resistant TB MDR / XDR
MRSA / CRE hospital superbugs